CMV REACTIVATION AFTER STOPPING LETERMOVIR PRIMARY PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS

被引：0
|
作者：
Chavaz, Lara [1 ]
Royston, Lena [1 ]
Masouridi-Levrat, Stavroula [1 ]
Mamez, Anne-Claire [1 ]
Giannotti, Federica [1 ]
Morin, Sarah [1 ]
Van Delden, Christian [1 ]
Chalandon, Yves [1 ]
Neofytos, Dionysios [1 ]
机构：
[1] Univ Hosp Geneva, Geneva, Switzerland
来源：
BONE MARROW TRANSPLANTATION | 2023年 / 58卷 / SUPP1期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
O102
引用
收藏
页码：93 / 93
页数：1
相关论文
共 50 条
  • [1] CMV Infection After Letermovir Primary Prophylaxis Discontinuation in Allogeneic Hematopoietic Cell Transplant Recipients
    Chavaz, Lara
    Royston, Lena
    Masouridi-Levrat, Stavroula
    Mamez, Anne-Claire
    Giannotti, Federica
    Morin, Sarah
    Van Delden, Christian
    Chalandon, Yves
    Neofytos, Dionysios
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (04):
  • [2] Efficacy and Pharmacoeconomic Impact of Letermovir for CMV Prophylaxis in Allogeneic Hematopoietic Cell Transplant Recipients
    Merchant, Shelby Lorraine
    Gatwood, Katie S.
    Satyanarayana, Gowri
    Byrne, Michael T.
    Kassim, Adetola A.
    Jagasia, Madan
    Savani, Bipin
    Engelhardt, Brian G.
    Culos, Kathryn Ann A.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [3] Letermovir prophylaxis for cytomegalovirus reactivation in allogeneic hematopoietic cell transplant recipients: Single center Canadian data
    Pang, Ian
    Chen, Peggy
    Trinh, Gertrude V.
    Remberger, Mats
    Novitzky-Basso, Igor
    Gerbitz, Armin
    Kim, Dennis D.
    Kumar, Rajat
    Lam, Wilson
    Law, Arjun D.
    Lipton, Jeffrey H.
    Viswabandya, Auro
    Pasic, Ivan
    Mattsson, Jonas
    Michelis, Fotios V.
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 112 (02) : 301 - 309
  • [4] Impact of Letermovir Prophylaxis on Voriconazole Exposure in Allogeneic Hematopoietic Cell Transplant Recipients
    Hamadeh, Issam S.
    Grunwald, Michael R.
    Martin, Allison
    Patel, Jai N.
    Shillingburg, Alexandra
    Kachur, Ekaterina
    Cook, Allene
    Karabinos, Allison
    Ai, Jing
    Knight, Thomas G.
    Ragon, Brittany K.
    Chojecki, Aleksander L.
    Shah, Nilay A.
    Sanikommu, Srinivasa R.
    Avalos, Belinda R.
    Copelan, Edward A.
    Shahid, Zainab
    [J]. BLOOD, 2020, 136
  • [5] Letermovir Prophylaxis for CMV Reactivation in Allogeneic Stem Cell Recipients: Α Retrospective Single Center Analysis
    Koch, Katrin
    Osswald, Lena
    Miller, Isabella
    Braitsch, Krischan
    Goetze, Katharina
    Bassermann, Florian
    Herhaus, Peter
    Verbeek, Mareike
    [J]. ANTICANCER RESEARCH, 2022, 42 (11) : 5431 - 5441
  • [6] Letermovir prophylaxis reduces the risk for CMV reactivation after allogeneic stem cell transplantation
    Koch, K.
    Herhaus, P.
    Osswald, L.
    Braitsch, K.
    Bassermann, F.
    Verbeek, M.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 62 - 62
  • [7] Letermovir prophylaxis and cytomegalovirus reactivation in adult allogeneic hematopoietic cell transplant recipients with graft versus host disease.
    Wolfe, Delaney
    Zhao, Qiuhong
    Siegel, Emma G.
    Puto, Marcin M.
    Efebera, Yvonne Adeduni
    Tossey, Justin C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [8] A Mortality Analysis of Letermovir Prophylaxis for Cytomegalovirus (CMV) in CMV-seropositive Recipients of Allogeneic Hematopoietic Cell Transplantation
    Ljungman, Per
    Schmitt, Michael
    Marty, Francisco M.
    Maertens, Johan
    Chemaly, Roy F.
    Kartsonis, Nicholas A.
    Butterton, Joan R.
    Wan, Hong
    Teal, Valerie L.
    Sarratt, Kendra
    Murata, Yoshihiko
    Leavitt, Randi Y.
    Badshah, Cyrus
    [J]. CLINICAL INFECTIOUS DISEASES, 2020, 70 (08) : 1525 - 1533
  • [9] Risk Factors for CMV Reactivation and Disease Among Hematopoietic Stem Cell Transplant Recipients Defining the Target Population for Letermovir Prophylaxis
    Ngyuen, Thao
    Kaivers, Jennifer
    Adams, Ortwin
    Lubke, Nadine
    Schroeder, Thomas
    Rautenberg, Christina
    Baermann, Ben-Niklas
    Ulrych, Thomas
    Haas, Rainer
    Timm, Joerg
    Kondakci, Mustafa
    Kobbe, Guido
    [J]. BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 497 - 498
  • [10] Letermovir for prophylaxis of cytomegalovirus manifestations in adult allogeneic hematopoietic stem cell transplant recipients
    Van Hecke, Sam
    Calcoen, Bas
    Lagrou, Katrien
    Maertens, Johan
    [J]. FUTURE MICROBIOLOGY, 2019, 14 (03) : 175 - 184
12345